| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 7e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |